Q4 2022 Vivoryon Therapeutics NV Earnings Call Transcript

Apr 19, 2023 / 01:00PM GMT
Operator

Good day, and thank you for standing by. Welcome to the Full Year 2022 Results Earnings Call. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, [Anne Doering]. Please go ahead.

Unidentified Company Representative -

Thank you, Heidi. Good afternoon, and thank you for joining us today for Vivoryon's conference call to discuss the company's full year 2022 results and operational progress. This morning, Vivoryon issued a press release reporting its full year 2022 results, which is posted on the company's website at www.vivoryon.com.

On the call with me today are Uli Dauer, Chief Executive Officer of Vivoryon; and Florian Schmid, our Chief Financial Officer. Also with us on today's call and available for questions is Michael Schaeffer, our Chief Business Officer. We will begin today's call with opening remarks from Uli on Vivoryon's clinical and operational progress and then Florian will review the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot